Core Viewpoint - The article discusses the legal dispute between Tianqi Materials and Yongtai Technology regarding the infringement of trade secrets, highlighting the implications for the involved companies and the lithium industry as a whole [1][2][3]. Group 1: Legal Proceedings - Tianqi Materials has officially filed a civil lawsuit against Yongtai Technology, claiming economic losses of 887 million yuan and legal fees of 1.15 million yuan [2]. - The lawsuit involves multiple defendants, including Yongtai Technology and its subsidiaries, with allegations of intentional infringement of trade secrets [2][4]. - The court proceedings are still pending, and the actual impact on the companies will depend on the court's final judgment [2][4]. Group 2: Background of the Dispute - The conflict traces back to a meeting arranged by Zhejiang Yanyi over four years ago, involving former Tianqi engineer Li Sheng, who allegedly provided proprietary technology to Yanyi [5][6]. - Li Sheng's actions included sharing sensitive production process information with Yanyi, which he obtained while still employed at Tianqi [6][8]. - The technology in question pertains to the production of liquid lithium salts, a critical component in the lithium battery industry [6][7]. Group 3: Industry Context - The lithium salt market has seen significant fluctuations, with prices rising sharply due to increased demand from the electric vehicle sector [24][26]. - Tianqi Materials claims to be the only company in China with industrialized production technology for liquid dual fluorine and liquid hexafluorophosphate lithium [6][24]. - The ongoing legal disputes reflect broader trends in the lithium industry, where intellectual property rights are increasingly contested amid rapid technological advancements [25][26]. Group 4: Financial Implications - Yongtai Technology's liquid lithium salt project is projected to generate significant revenue, with estimates of 5.4 billion yuan in annual income and 670 million yuan in net profit once fully operational [19]. - However, the ongoing legal issues and market conditions have raised concerns about Yongtai's financial performance, with reports of consecutive losses [19][24]. - The outcome of the lawsuit could have substantial financial repercussions for both Tianqi and Yongtai, particularly if damages are awarded [16][17].

Core Viewpoint - Tianqi Materials has filed a civil lawsuit against Yongtai Technology and others for commercial secret infringement, claiming an expected economic loss of 887 million yuan and legal fees of 1.15 million yuan [2][5]. Group 1: Legal Proceedings - Tianqi Materials' subsidiary, Jiujiang Tianqi High-tech Materials Co., Ltd., is the plaintiff in the lawsuit filed in Jiangxi Province [2]. - The defendants include Yongtai Technology, Shaowu Yongtai High-tech Materials Co., Ltd., and several individuals, with claims of intentional infringement [2][3]. - The lawsuit seeks to destroy production line equipment and technical documents used in the production of 134,000 tons of liquid lithium salt, which allegedly utilized Tianqi's trade secrets [3][12]. Group 2: Background of the Dispute - The dispute traces back to a meeting arranged by Zhejiang Yan Yi, where former Tianqi engineer Li Sheng was allegedly offered high consulting fees and equity incentives to share proprietary technology [6][10]. - Li Sheng, after leaving Tianqi, is accused of illegally transferring proprietary technology to Zhejiang Yan Yi and Yongtai Technology [7][10]. - The technology in question includes processes for producing liquid lithium hexafluorophosphate and liquid dual fluorine, which are critical in the lithium battery industry [7][25]. Group 3: Financial Implications - The expected economic loss claimed by Tianqi Materials amounts to 887 million yuan, reflecting the significant financial stakes involved in the case [2][16]. - Yongtai Technology's 134,000 tons liquid lithium salt project is projected to generate annual revenues of 5.4 billion yuan and net profits of 670 million yuan once fully operational [19][20]. - The ongoing legal issues may impact Yongtai Technology's financial performance, as it has reported consecutive losses despite expanding production capacity [19][20]. Group 4: Industry Context - The lithium salt market has seen significant fluctuations, with prices for lithium hexafluorophosphate rising sharply due to increased demand from the electric vehicle sector [25][26]. - The case highlights the growing trend of intellectual property disputes within the lithium battery industry, reflecting the competitive landscape and the importance of proprietary technology [26][27]. - Recent judicial interpretations have increased penalties for commercial secret infringements, indicating a stricter enforcement environment for intellectual property rights [26][27].

永太科技：公司可能涉及诉讼 但尚未收到相关材料 智通财经7月2日电，永太科技(002326.SZ)公告称，公司关于公司提起诉讼的公告，披露了九江天赐高 新材料有限公司对公司及控股子公司邵武永太高新材料有限公司就商业秘密侵权纠纷案件向江西省高级 人民法院提起民事诉讼。公司尚未收到任何涉及该案的诉讼材料，且所研发的生产工艺具有完全自主的 知识产权，因此该诉讼案件不会对公司核心技术和自主研发能力产生影响。目前无法预计对公司本期及 期后损益的影响，最终实际影响以实际发生诉讼案件的法院生效判决为准。公司将积极应诉，依法主张 自身合法权益，并及时履行信息披露义务。 ...

公司一直以来尊重他人知识产权和重视知识产权保护，所研发的生产工艺具 有完全自主的知识产权，本公告涉及的可能发生的诉讼案件不会对公司核心技术 和自主研发能力产生影响。同时，公司始终坚守公平竞争的原则，反对滥用市场 支配地位等一切形式的市场垄断和不正当竞争行为，倡导以创新与合作推动行业 健康发展，任何试图通过非正当手段谋取市场优势地位的行为都难以逃脱法律和 市场规则的约束。 鉴于公司尚未收到有关该诉讼案件的任何材料和信息，对《广州天赐高新材 料股份有限公司关于公司提起诉讼的公告》所述的相关诉讼案件以及诉讼案件的 后续结果都尚不确定，同时公司目前仅生产固态六氟磷酸锂产品，尚未生产销售 该案件所涉的液态六氟磷酸锂产品，目前无法预计对公司本期及期后损益的影响， 最终实际影响以实际发生诉讼案件的法院生效判决为准。 证券代码：002326 证券简称：永太科技 公告编号：2025-043 浙江永太科技股份有限公司 关于公司可能涉及诉讼的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 近日，浙江永太科技股份有限公司（以下简称"公司"）关注到，《广州天 赐高新材料股份有限公 ...

天赐材料：公司全资子公司提起商业秘密侵权诉讼 涉案金额预期经济损失8.87亿元 智通财经7月2日电，天赐材料(002709.SZ)公告称，公司全资子公司九江天赐高新材料有限公司作为原 告，就商业秘密侵权纠纷案件向江西省高级人民法院提起民事诉讼，涉案金额预期经济损失8.87亿元及 律师费115万元。涉案被告包括浙江永太科技股份有限公司、邵武永太高新材料有限公司等。原告认为 被告具有明显的侵权故意，应承担连带赔偿责任。该诉讼事项预计不会对公司当期损益产生直接的负面 影响，但案件尚未开庭审理，最终实际影响以法院判决为准。 ...

Company Overview - Zhejiang Yongtai Technology Co., Ltd. was established in 1999 and listed in 2009, headquartered in Taizhou, Zhejiang Province, specializing in fluorine fine chemicals manufacturing [2][3] - The company covers new materials (lithium battery and fluorinated liquid materials), pharmaceuticals, plant protection, and trade, with a comprehensive product range across the upstream and downstream supply chain [2][3] Performance and Financials - In 2024, the company achieved a revenue of CNY 458,939.78 million, a year-on-year increase of 11.18%, with a net profit loss reduced by 36.26% [4] - The lithium battery materials segment showed significant improvement with a gross margin increase of 23.07 percentage points; the plant protection segment's revenue grew by 91.79% [4] - In Q1 2025, the company reported a revenue of CNY 105,995.92 million and a net profit of CNY 1,057.75 million [4] Business Segments Trade Segment - The trade segment, led by subsidiary Shanghai Nonghui, focuses on the sale of pesticide raw materials and formulations, holding over 1,500 overseas pesticide registration certificates [5] Plant Protection Segment - The growth in the plant protection business was driven by three factors: market recovery post-inventory adjustment, new production lines coming online, and proactive customer expansion [6][7] Lithium Battery Technology - The company prioritizes the development of medium and long-term lithium battery technology, enhancing collaboration with industry partners for application research [8] - The commercialization timeline for this technology remains uncertain, dependent on R&D progress and market conditions [9] Fluorinated Liquid Products - The fluorinated liquid business has established a small-scale order base, with plans for rapid growth through product optimization and market expansion [10] - The market for fluorinated liquids is expanding due to advancements in AI, high-performance computing, and semiconductor manufacturing, though challenges remain [11] Future Growth Strategies - Profit growth will be driven by expanding lithium materials capacity, stable demand in pharmaceuticals, global expansion in plant protection, and breakthroughs in new businesses like fluorinated liquids [12] - The company is exploring solid-state battery technology, maintaining communication with industry partners to adapt to market needs [12] Pharmaceutical Business Development - The pharmaceutical segment will focus on high-value formulations, leveraging procurement opportunities to penetrate the domestic market, and enhancing market development capabilities through specialized teams [13] Financing Plans - Currently, there are no plans for additional financing; future decisions will be based on project progress and funding needs [15]

证券代码：002326 证券简称：永太科技 公告编号：2025-042 浙江永太科技股份有限公司 关于为子公司提供担保的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 一、担保情况概述 浙江永太科技股份有限公司（以下简称"公司"）经 2025 年 5 月 19 日召开 的 2024 年年度股东大会审议通过，同意公司对纳入合并报表范围内的部分子公 司提供累计总额不超过人民币 430,000 万元的担保，该担保额度可循环使用，即 为其向国内各类银行及其他机构的融资（包括但不限于人民币/外币贷款、银行承 兑、信用证开证、进出口押汇、打包贷款、银行保函、融资租赁等）提供连带责 任保证。其中对资产负债率未超过 70%的部分子公司提供担保额度不超过 200,000 万元，对资产负债率超过 70%的部分子公司提供担保额度不超过 230,000 万元。担保额度可在子公司之间进行调剂，但在调剂发生时，资产负债率超过 70% 的担保对象，仅能从资产负债率超过 70%的担保对象处获得担保额度。担保方式 包括但不限于保证、抵押、质押，具体担保金额及保证期间按具体合同约定执行。 ...

证券代码：002326 证券简称：永太科技 公告编号：2025-041 浙江永太科技股份有限公司 关于为子公司提供担保的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 一、担保情况概述 成立日期：2019 年 10 月 22 日 注册地址：内蒙古自治区乌海市海南区乌海高新技术产业开发区低碳产业园 西环路 1 号 法定代表人：王梓臣 注册资本：129,100 万元 经营范围：许可项目：农药生产；危险化学品生产；危险化学品经营。（依 法须经批准的项目，经相关部门批准后方可开展经营活动，具体经营项目以相关 部门批准文件或许可证件为准）一般项目：化工产品生产（不含许可类化工产品）； 化工产品销售（不含许可类化工产品）；基础化学原料制造（不含危险化学品等 许可类化学品的制造）；机械设备销售；仪器仪表销售；技术服务、技术开发、 技术咨询、技术交流、技术转让、技术推广；货物进出口。（除依法须经批准的 项目外，凭营业执照依法自主开展经营活动） 与本公司的关系：内蒙古永太为公司的全资子公司。 浙江永太科技股份有限公司（以下简称"公司"）经 2025 年 5 月 19 日召 ...

Core Viewpoint - Yongtai Technology is experiencing a significant recovery in its operational quality, with a notable reduction in losses and growth in key business segments, indicating a positive outlook for future development. Group 1: Company Overview - Yongtai Technology, established in 1999 and listed in 2009, is a leading manufacturer of fluorine fine chemicals, with a diversified product matrix covering new materials, pharmaceuticals, plant protection, and trade [1]. - The company has multiple production bases in Zhejiang, Inner Mongolia, Fujian, and Guangdong, ensuring sufficient capacity for sustainable development [1]. Group 2: Financial Performance - The company reported a 36.26% year-on-year reduction in losses, indicating improved operational quality [2]. - The lithium battery materials segment saw a gross margin increase of 23.07 percentage points year-on-year, reflecting a recovery in core business profitability [2]. - The plant protection segment's revenue grew by 91.79% year-on-year, showcasing strong market demand [2]. - For Q1 2025, Yongtai Technology achieved a revenue of 1,059.96 million yuan and a net profit attributable to shareholders of 10.58 million yuan [2]. Group 3: Strategic Development - In the lithium battery materials sector, the company is implementing cost reduction and efficiency enhancement measures, with production and sales of electrolyte solutions increasing [3]. - Yongtai Technology has a production capacity of 67,000 tons/year for lithium bis(fluorosulfonyl)imide (LiFSI), with steadily improving capacity utilization and decreasing production costs [3]. - The company is focusing on long-term strategic planning in lithium battery technology and enhancing R&D collaboration to improve technological maturity [3]. Group 4: Market Expansion - In the pharmaceutical sector, Yongtai Technology aims to develop high-value-added formulation products and has won bids for centralized procurement in several provinces [4]. - The company has established a professional marketing team to expand its domestic market share [4]. - In the plant protection business, Yongtai Technology covers key production processes and is enhancing production and sales integration through its subsidiary, Shanghai Nonghui, which holds over 1,500 overseas pesticide registration certificates [4].

Company Overview - Zhejiang Yongtai Technology Co., Ltd. was established in 1999 and listed in 2009, headquartered in Taizhou, Zhejiang Province. It is a global leader in fluorine fine chemicals, covering both inorganic and organic fluorochemical industries [2][3]. - The company has multiple production bases in Zhejiang, Inner Mongolia, Fujian, and Guangdong, with sufficient existing, under-construction, and planned capacities to support future growth [2]. Financial Performance - In 2024, the company achieved a revenue of CNY 458,939.78 million, representing an 11.18% year-on-year growth. The net profit, after deducting non-recurring items, showed a loss reduction of 36.26% [3]. - The lithium battery materials segment saw a significant improvement, with a gross margin increase of 23.07 percentage points. The plant protection segment's revenue grew by 91.79%, enhancing market competitiveness [3]. - In Q1 2025, the company reported a revenue of CNY 105,995.92 million and a net profit of CNY 1,057.75 million [3]. Lithium Battery Technology Development - The company is focusing on the strategic development of long-duration lithium battery technology, emphasizing collaboration in research and development to enhance technical maturity [4]. - The timeline for industrialization of this technology is uncertain and will depend on various factors, including technical validation and market conditions [5]. Lithium Battery Materials Segment - The profitability of the lithium battery materials segment is influenced by raw material price fluctuations and supply-demand dynamics. The company has implemented cost-reduction and efficiency-enhancing measures [7]. - The production capacity for liquid dual fluorine (LiFSI) is currently 67,000 tons per year, with a steady increase in utilization and a reduction in production costs [9]. Market Outlook and Strategies - The company anticipates that the price trends for lithium battery materials will be affected by market supply-demand, raw material costs, and industry policies, making future predictions challenging [8]. - The company is actively expanding its market share in the lithium battery materials sector and enhancing its competitive edge [7]. Pharmaceutical and Plant Protection Segments - In the pharmaceutical sector, the company aims to develop high-value-added formulation products and has established a dedicated marketing team covering 26 provinces and regions [11]. - The plant protection business includes a comprehensive product layout covering pesticide intermediates, active ingredients, and formulations, with a focus on international trade [11].